DaVita (NYSE:DVA) Reaches New 12-Month High – What’s Next?

DaVita Inc. (NYSE:DVA)’s share price reached a new 52-week high on Wednesday . The stock traded as high as $211.95 and last traded at $208.9090, with a volume of 765773 shares traded. The stock had previously closed at $209.75.

Wall Street Analysts Forecast Growth

DVA has been the topic of a number of research analyst reports. Truist Financial boosted their price objective on shares of DaVita from $158.00 to $205.00 and gave the company a “hold” rating in a research report on Friday, May 8th. TD Cowen boosted their price objective on shares of DaVita from $144.00 to $201.00 and gave the company a “hold” rating in a research report on Monday, May 11th. Zacks Research raised shares of DaVita from a “hold” rating to a “strong-buy” rating in a research report on Thursday, May 7th. Deutsche Bank Aktiengesellschaft raised shares of DaVita from a “hold” rating to a “buy” rating and boosted their price objective for the company from $126.00 to $220.00 in a research report on Wednesday, May 6th. Finally, Wall Street Zen raised shares of DaVita from a “hold” rating to a “buy” rating in a research report on Saturday, February 21st. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, DaVita has a consensus rating of “Hold” and a consensus price target of $199.17.

DaVita Stock Performance

The company has a market capitalization of $13.41 billion, a PE ratio of 19.38, a P/E/G ratio of 0.69 and a beta of 0.91. The stock has a 50 day moving average price of $178.66 and a two-hundred day moving average price of $147.52.

DaVita (NYSE:DVA) last posted its earnings results on Tuesday, May 5th. The company reported $2.87 EPS for the quarter, topping the consensus estimate of $2.33 by $0.54. The company had revenue of $3.42 billion during the quarter, compared to the consensus estimate of $3.36 billion. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The company’s revenue for the quarter was up 6.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.00 earnings per share. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. Sell-side analysts predict that DaVita Inc. will post 15.07 earnings per share for the current year.

Insider Buying and Selling

In other DaVita news, CFO Joel Ackerman sold 51,471 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $192.10, for a total value of $9,887,579.10. Following the completion of the sale, the chief financial officer directly owned 132,434 shares of the company’s stock, valued at $25,440,571.40. The trade was a 27.99% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.50% of the stock is owned by corporate insiders.

Institutional Trading of DaVita

Large investors have recently added to or reduced their stakes in the business. Doma Perpetual Capital Management LLC grew its position in DaVita by 23.3% in the third quarter. Doma Perpetual Capital Management LLC now owns 355,574 shares of the company’s stock worth $47,245,000 after acquiring an additional 67,214 shares in the last quarter. Intech Investment Management LLC boosted its holdings in shares of DaVita by 122.4% during the 3rd quarter. Intech Investment Management LLC now owns 27,441 shares of the company’s stock worth $3,646,000 after buying an additional 15,104 shares during the period. Nordea Investment Management AB boosted its holdings in shares of DaVita by 18.0% during the 4th quarter. Nordea Investment Management AB now owns 338,192 shares of the company’s stock worth $38,321,000 after buying an additional 51,607 shares during the period. Munich Reinsurance Co Stock Corp in Munich bought a new position in DaVita in the 3rd quarter worth $5,419,000. Finally, WINTON GROUP Ltd bought a new position in DaVita in the 3rd quarter worth $5,755,000. 90.12% of the stock is owned by institutional investors.

About DaVita

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.